Skip to content

Nosocomial Influenza Surveillance 2018 - 2022

Surveillance of Nosocomial Influenza at Edouard Herriot University Hospital, Lyon, France.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03413228
Acronym
NOSOGRIPPE
Enrollment
500
Registered
2018-01-29
Start date
2018-02-28
Completion date
2022-06-30
Last updated
2018-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospital-Acquired Infection, Influenza

Brief summary

Hospital-acquired influenza is associated with significant morbidity and mortality in hospitalized patients notably elderly patients. Furthermore, it is also associated with a large economic impact for the hospitals. The transmission of influenza has been mostly reported in pediatric and long-stay units. The chains of transmission of influenza in acute-stay units have to be describe in order to prevent and control potential outbreaks. Furthermore, to know clinical symptoms seems to be important in order to identify potential sources of virus as soon as possible and to set up appropriate hygiene prevention measures. Moreover, the definition of the hospital-acquired influenza has to be harmonized for all over the studies, especially concerning the delay between the admission in the hospital and the symptoms onset. The aim of this study is to describe the hospital-acquired influenza in a french university hospital of around 800 beds

Interventions

OTHERQuestionnaire

An interview to collect some informations will be done: demographic informations, medical history, vaccination against influenza status, symptoms and virological informations. Then, a nasal swab was performed in order to identified the influenza virus.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adult patients and health-care workers in a participating unit in the study, * more than 18 years old, * volunteers, * who present an influenza-like illness defined by fever \> 37,8°C or/and cough or sore throat.

Exclusion criteria

-Everyone who does not present the inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients and health-care workers who present an influenza illness.5 days maximumAn interview to collect some informations will be done to evaluate if participants present symptoms of an inflenza illness (fever \> 37,8°C or/and cough or sore throat). Then, a nasal swab will be performed in order to identified the influenza virus.

Countries

France

Contacts

Primary ContactPhilippe VANHEMS, MD PhD
philippe.vanhems@chu-lyon.fr0472110719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026